Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Dec 16, 2021; 13(12): 571-592
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.571
Published online Dec 16, 2021. doi: 10.4253/wjge.v13.i12.571
Type of choledochoscope | Fibreoptic or digital-based imaging systems1 | Outer diameter (mm) | Accessory working channel diameter (mm) | Tip deflections |
Percutaneous | ||||
CHF-CB30 L/S (Olympus Medical Systems, Tokyo, Japan)[13] | Digital | 2.8 | 1.2 | 2-way (up-down) |
Peroral – dual-operator | ||||
Mother-baby[4] | Fibreoptic | “Mother”: 12.6 mm “Baby”: 2.8–3.4 mm | 0.8 – 1.2 | 2-way (up-down) |
Short-access-mother-baby (Karl Storz, Tuttlingen, Germany)[4] | Fibreoptic | “Mother”: 12.6 mm “Baby”: 3.4 mm | 1.5 | 2-way (up-down) |
Videocholangioscope (CHF-B290; Olympus Medical Systems, Tokyo, Japan )[6] | Digital | 3.3 | 1.3 | 2-way (up-down) |
Peroral – Single-Operator | ||||
SpyGlass Legacy 2007 (Boston Scientific Corporation, Natick, MA, United States)[5] | Fibreoptic | 3.3 | 1.2 | 4-way (up-down, left-right) |
SpyGlass Direct Visualisation 2015 (Boston Scientific Corporation, Natick, MA, United States)[5] | Digital | 3.6 | 1.2 | 4-way (up-down, left-right) |
SpyGlass Direct Visualisation II 2018 (Boston Scientific Corporation, Natick, MA, United States) | Digital | Data has not been published yet | ||
Direct peroral choledochoscopy using variety of ultra-thin endoscopes[5] | Digital | 5.0 – 5.9 | 2.0 | 4-way (up-down, left-right) |
Type of choledochoscopy | Advantages | Disadvantages |
Peroral (endoscopic) | Natural orifice | (1) Technical expertise; (2) Sedation or anesthesia; and (3) Not possible in patients with previous gastric resections or Roux-en-Y gastric bypass |
Percutaneous transhepatic (interventional radiology) | (1) Shorter scope length; (2) Repeated with ease; and (3) Therapeutic interventions | (1) Need dilated intra-hepatic ducts; and (2) Risk of bleeding, bile leak, tumor seeding, biliary fistula and skin excoriation |
Percutaneous transenteric via access loop (interventional radiology, surgical) | (1) Shorter scope length; (2) Repeated with ease; (3)Therapeutic interventions; (4) Ductal dilatation not necessary; and (5) In patients with RPC | (1) Previous access loop creation; and (2) Risk of small bowel injury, peritonitis, biliary fistula and skin excoriation |
Intra-operative transcystic (surgical) | (1) Avoid CBD incision; (2) Therapeutic interventions; (3) Can document CBD clearance; and (4) It can be done laparoscopically | (1) The spiral valve of Heister; (2) Anatomy of the cystic duct; (3) Size of the cystic duct; (4) Need thin scopes (3 mm); (5) Technical expertise; and (6) Risks of bleeding, bile leak |
Intra-operative transcholedochal (surgical) | Most direct access | (1) Need dilated extra-hepatic biliary system; (2) Risk of bleeding, bile leak; (3) Can put an internal stent; and (4) Can put T tube |
Diagnostic indications | Therapeutic indications |
Visual impression and visually-guided biopsies of: (1) Indeterminate biliary strictures (IBS); (2) Dominant strictures in primary sclerosing cholangitis (PSC); and (3) IgG4-related sclerosing cholangitis (IgG4-SC) | Stone fragmentation: (1) Electrohydraulic lithotripsy (EHL); and (2) Laser lithotripsy (LL) |
Precise preoperative mapping of the extent of tumor involvement in CCA | Ablative therapies in cholangiocarcinoma (CCA): (1) Radiofrequency ablation; (2) Photodynamic therapy; (3) Nd:YAG laser ablation; and (4) Argon plasma coagulation |
Choledochal cysts | Cystic duct stent placement |
Intraductal papillary neoplasms of the bile duct | Guidewire passage through strictures, surgically altered anatomy |
Cholangioadenoma | Resection of ductal masses |
Biliary papillomatosis | Retrieval of migrated ductal stents |
Eosinophilic cholangitis | Gallbladder stenting and drainage |
Biliary varices | |
Right Hepatic Artery Syndrome | |
Congenital pancreaticobiliary maljunction | |
Post-liver transplant ductal ischemia | |
Tissue sampling and visual evaluation for infections: (1) Cytomegalovirus; and (2) HIV | |
Evaluation of intrahepatic biliary tracts during minimally invasive surgery |
- Citation: Lee T, Teng TZJ, Shelat VG. Choledochoscopy: An update. World J Gastrointest Endosc 2021; 13(12): 571-592
- URL: https://www.wjgnet.com/1948-5190/full/v13/i12/571.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i12.571